Welcome to Sozo
In every corner of the globe, life-threatening diseases cry out for treatment.
Our extensive product portfolio includes pharmaceuticals for infection, oncology, neuroscience, cardiovascular care and respiratory care.
99%
reported in developing countries Infectious diseases remain one of the leading causes of morbidity and mortality around the world accounting for more than 52 million.
96
studies that tested 50 samples or more (67,839 total drug samples) show poor-quality essential medicines are a substantial and understudied problem.
80%
of people in high-income countries had received at least one COVID-19 vaccine dose compared to only 23% of those in low-income countries.
Sozo Products
Antibiotics/Analgesic
Physicians and public health officials around the world are increasingly concerned about bacterial infections, many of which are highly resistant to antibiotics.
Infectious Disease and Ambulatory Care
Intensive care is the most costly and technologically advanced area of medicine.
Oncology
Experts say that deaths from cancer worldwide will continue to rise, with an estimated 12 million deaths annually by 2030.
Partnerships for Success
Our extensive product portfolio includes pharmaceuticals for infection, oncology, neuroscience, cardiovascular care and respiratory care. We promote co-development and discovery through a network of partnerships and affiliations. Thus we can deliver to markets around the world a myriad of medications that are safe and cost-effective.
“Since starting my meds, my chronic pain has significantly reduced, allowing me to finally enjoy activities I used to love.”
Sozo Customer
Federal Employee
Our goal is to improve the lives of our customers and consumers by empowering not just individuals but whole communities, as well as local and national governments, countries, and continents.